Piper Jaffray Starts TELA Bio, Inc. (TELA) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts TELA Hot Sheet
Price: $0.97 -3.96%
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
Piper Jaffray analyst Matt O/Briend initiates coverage on TELA Bio, Inc. (NASDAQ: TELA) with a Overweight rating and a price target of $17.00.
For an analyst ratings summary and ratings history on TELA Bio, Inc. click here. For more ratings news on TELA Bio, Inc. click here.
Shares of TELA Bio, Inc. closed at $12.31 yesterday.
You May Also Be Interested In
- Citi Starts Yamazaki Baking Co Ltd (2212:JP) at Buy
- Roth/MKM Starts Natera (NTRA) at Buy
- Citi Starts Japan Tobacco Inc. (2914:JP) (JAPAY) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
